SRC and breast carcinoma: Since both c-Src and Brk tyrosine kinases are frequently overexpressed in breast cancer and since they both mediate Y699 phosphorylation of STAT5b, there is potential for these kinases to either substitute for one another or work together to activate STAT5b.